Literature DB >> 7560596

Identification of patent foramen ovale permitting paradoxic embolism.

D Hausmann1, A Mügge, W G Daniel.   

Abstract

OBJECTIVES: We sought to analyze the morphologic and functional characteristics of the patent foramen ovale in patients with different clinical likelihoods for paradoxic embolism.
BACKGROUND: The incidence of patent foramen ovale is increased in patients with otherwise unexplained arterial ischemic events. Because signs of venous thrombosis are absent in most patients, the diagnosis of paradoxic embolism is often questioned, even when patent foramen ovale is the only potential explanation for the ischemic event.
METHODS: Seventy-eight patients with a patent foramen ovale detected by contrast transesophageal echocardiography were studied: 21 patients with an otherwise unexplained arterial ischemic event and clinical evidence implying paradoxic embolism (group I), 30 patients with an unexplained ischemic event but no clinical evidence for paradoxic embolism (group II) and 27 patients without an ischemic event (group III).
RESULTS: During transesophageal contrast echocardiography, patients in group I had more severe right to left shunting (mean +/- SD 52 +/- 16% of the left atrial area filled with contrast medium) and a wider opening of the patent foramen ovale (7.1 +/- 3.6-mm separation between the septum primum and the septum secundum) than did patients in group II (35 +/- 15% and 4.4 +/- 3.2 mm, respectively, p < 0.001) or group III (23 +/- 12% and 3.0 +/- 2.0 mm, respectively, p < 0.001). The incidence of atrial septal aneurysm was similar in the three groups. Severe contrast shunting (> or = 50% of the left atrial area filled with contrast medium) and wide opening of the patent foramen ovale (> or = 5-mm separation) revealed a high sensitivity (71% and 86%, respectively) and high specificity (86% and 96%, respectively) for identification of group I patients.
CONCLUSIONS: Right to left contrast shunting is more severe and opening of the patent foramen ovale is larger in patients with ischemic arterial events considered to be due to paradoxic embolism. In patients with a patent foramen ovale as the only potential cause for ischemic events and no signs of venous thrombosis, morphologic and functional variables assessed by transesophageal echocardiography may be helpful in estimating the likelihood of paradoxic embolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7560596     DOI: 10.1016/0735-1097(95)00288-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  28 in total

1.  Transcranial Doppler ultrasonography in the detection of venous to arterial shunting in acute stroke and transient ischaemic attacks.

Authors:  M Yeung; K A Khan; A Shuaib
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-11       Impact factor: 10.154

2.  [Position paper on quality standards in echocardiography].

Authors:  R Hoffmann
Journal:  Z Kardiol       Date:  2004-12

3.  Patent foramen ovale and stroke: prognosis and treatment in young adults.

Authors:  Steven C Cramer
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

4.  [Pulmonary embolism with paradoxical coronary and peripheral arterial embolization. Increased risk of thrombosis caused by contraception with desogestrel and ethinylestradiol?].

Authors:  J Brockmeier; J Carlsson; S Miketic; R Meierhenrich; E Sorges; L Obergassel; U Tebbe
Journal:  Med Klin (Munich)       Date:  1997-01-15

Review 5.  Current status of percutaneous PFO closure.

Authors:  N Rohrhoff; J P Vavalle; S Halim; T L Kiefer; J K Harrison
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

6.  Role of occlusive devices to prevent thromboembolism among persons with a patent foramen ovale and prior stroke.

Authors:  Christopher Roth; Oluseun Alli
Journal:  Curr Treat Options Neurol       Date:  2015-03       Impact factor: 3.598

Review 7.  Management of patients with stroke and a patent foramen ovale.

Authors:  Carlos J Rodriguez; Shunichi Homma
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

8.  Cerebral microembolism during transcatheter closure of patent foramen ovale.

Authors:  J Ferrari; H Baumgartner; S Tentschert; V Dorda; W Lang; A Willfort-Ehringer; P Probst; W Lalouschek
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

9.  Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.

Authors:  Kumar Rajamani; Seemant Chaturvedi; Zhezhen Jin; Shunichi Homma; Robin L Brey; Barbara C Tilley; Ralph L Sacco; J L P Thompson; J P Mohr; Steven R Levine
Journal:  Stroke       Date:  2009-06-04       Impact factor: 7.914

10.  Patent Foramen Ovale and Stroke.

Authors:  Carlos J. Rodriguez; Shunichi Homma
Journal:  Curr Treat Options Cardiovasc Med       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.